Press coverage about McKesson (NYSE:MCK) has trended somewhat positive on Wednesday, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. McKesson earned a news sentiment score of 0.08 on Accern’s scale. Accern also gave news coverage about the company an impact score of 44.3152255671728 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
These are some of the news articles that may have impacted Accern Sentiment’s analysis:
- Tina Smith, Steve Bannon, Matt Lauer, DeRay McKesson, Mo Brooks Cancer, Dear Evan Hansen, Michael Che: HOT … – Towleroad (towleroad.com)
- Sales Growth Hurt McKesson (MCK) Rating (investorplace.com)
- Zacks: Analysts Anticipate McKesson Co. (MCK) Will Announce Quarterly Sales of $52.00 Billion (americanbankingnews.com)
- Home Healthcare Market by Product, Data Validation, Growth, Trends, Analysis and Forecasts to 2022 (emailwire.com)
- Minneapolis-based Meda recognized by U.S. Commerce Department (startribune.com)
Several research analysts recently weighed in on the stock. Royal Bank of Canada assumed coverage on shares of McKesson in a research report on Tuesday, September 19th. They set a “sector perform” rating and a $168.00 price target for the company. Jefferies Group set a $165.00 price target on shares of McKesson and gave the stock a “hold” rating in a research report on Wednesday, October 18th. Cowen upgraded shares of McKesson from a “market perform” rating to an “outperform” rating and upped their price target for the stock from $176.00 to $189.00 in a research report on Tuesday, October 10th. Needham & Company LLC set a $179.00 price target on shares of McKesson and gave the stock a “buy” rating in a research report on Monday, October 16th. Finally, BidaskClub downgraded shares of McKesson from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 19th. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating and twelve have given a buy rating to the stock. The stock currently has an average rating of “Buy” and a consensus price target of $174.31.
McKesson (MCK) traded up $0.74 during mid-day trading on Wednesday, reaching $154.55. 1,981,400 shares of the company’s stock were exchanged, compared to its average volume of 1,875,875. The firm has a market cap of $32,065.46, a P/E ratio of 12.65, a price-to-earnings-growth ratio of 1.58 and a beta of 1.23. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.61 and a current ratio of 1.05. McKesson has a 12 month low of $133.82 and a 12 month high of $169.29.
McKesson (NYSE:MCK) last released its quarterly earnings data on Thursday, October 26th. The company reported $3.28 EPS for the quarter, beating the Zacks’ consensus estimate of $2.78 by $0.50. The company had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.69 billion. McKesson had a net margin of 2.24% and a return on equity of 24.87%. McKesson’s quarterly revenue was up 4.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.94 EPS. analysts anticipate that McKesson will post 12.17 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 2nd. Shareholders of record on Friday, December 1st will be issued a $0.34 dividend. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $1.36 dividend on an annualized basis and a yield of 0.88%. McKesson’s payout ratio is 6.45%.
In other news, Chairman John H. Hammergren sold 225,000 shares of the stock in a transaction that occurred on Friday, September 22nd. The shares were sold at an average price of $151.67, for a total value of $34,125,750.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO John H. Hammergren sold 100,000 shares of the stock in a transaction that occurred on Wednesday, September 27th. The shares were sold at an average price of $155.30, for a total transaction of $15,530,000.00. Following the completion of the sale, the chief executive officer now directly owns 165,000 shares of the company’s stock, valued at approximately $25,624,500. The disclosure for this sale can be found here. In the last quarter, insiders sold 949,000 shares of company stock valued at $145,263,360. 1.20% of the stock is owned by insiders.
TRADEMARK VIOLATION NOTICE: “McKesson (MCK) Receives Daily Media Impact Rating of 0.08” was originally posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this article on another publication, it was illegally stolen and republished in violation of United States and international copyright and trademark legislation. The correct version of this article can be read at https://ledgergazette.com/2017/12/13/mckesson-mck-receives-daily-media-impact-rating-of-0-08.html.
McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare.
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.